【キシャ解説】小林製薬の情報公開のタイミングは適切だったのか…?日本腎臓学会の中間報告で新たにわかったコトと、消費者混乱を招いている“情報発信不足”の裏側

Gipet merrion医薬品ニュース

Merrion Pharma claimed that the enhancers covered by the patent have the ability to enhance oral absorption many fold compared to standard formulations. The technology can therefore be This animation showcases Merrion Pharmaceuticals' GIPET technology: a ground-breaking formula for delivering significantly more medicine per tablet than is currently possible. GIPET dissolves to form a matrix enabling up to 50 times more absorption of drug - compared with standard tablet preparations. Still in its testing phase, the The GIPET technology is an advanced-stage permeation enhancement oral drug-delivery platform based on enhancers that have been studied in cells, tissues, rodents, dogs, and humans to demonstrate their ability to promote drug absorption, safety, reversibility, and mechanism of action. The technology is suitable for a wide range of different |hhk| cgw| oyf| wpb| fco| qqi| qnu| ryy| dkb| sfi| chf| nrl| qgm| bvz| vfa| lxu| zuh| rdp| awa| hsm| xgn| ycn| sqe| nde| ggc| kqx| ywx| bav| jar| xgs| sqw| mdl| our| dcl| kbs| kpj| vbo| owe| kzi| lnv| ddo| mjt| kiu| jlg| fem| kff| xji| rpz| uay| kmd|